Bluejay Diagnostics Files Definitive Proxy Statement

TL;DR

Bluejay Diagnostics filed its proxy statement, shareholders vote soon.

AI Summary

Bluejay Diagnostics, Inc. filed a definitive proxy statement (DEF 14A) on September 10, 2024, for its annual meeting of stockholders. The filing indicates that no fee was required for this filing. The company is incorporated in Delaware and its fiscal year ends on December 31.

Why It Matters

This filing is crucial for shareholders as it outlines the agenda and proposals for the upcoming annual meeting, allowing them to make informed voting decisions.

Risk Assessment

Risk Level: low — This is a routine regulatory filing for a public company's annual meeting and does not contain new financial or operational information that would inherently increase risk.

Key Players & Entities

• Bluejay Diagnostics, Inc. (company) — Registrant
• 0001213900-24-077413 (filing_id) — Accession Number
• 20240910 (date) — Filing Date
• 20241023 (date) — Period of Report
• 3841 (sic_code) — Standard Industrial Classification
• 473552922 (irs_number) — IRS Number
• DE (state) — State of Incorporation
• 1231 (fiscal_year_end) — Fiscal Year End
• 001-41031 (sec_file_number) — SEC File Number

FAQ

Key Financial Figures

• $25,000 — e expect to pay Saratoga Proxy a fee of $25,000, plus reimbursement of reasonable and c
• $1.00 — nies to maintain a minimum bid price of $1.00 for continued inclusion on the Nasdaq C

Filing Documents

• ea0212810-04.htm (DEF 14A) — 344KB
• tproxy_001.jpg (GRAPHIC) — 1134KB
• tproxy_002.jpg (GRAPHIC) — 1079KB
• 0001213900-24-077413.txt ( ) — 3394KB

From the Filing

DEF 14A 1 ea0212810-04.htm PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________________ SCHEDULE 14A _________________________________ Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant   Filed by a Party other than the Registrant   Check the appropriate box:   Preliminary Proxy Statement   Confidential, for Use of the Commission Only (as permitted by Rule 14a -6 (e)(2))   Definitive Proxy Statement   Definitive Additional Materials   Soliciting Material under §240.14a -12 Bluejay Diagnostics, Inc. (Name of Registrant as Specified In Its Charter) ______________________________________________________________ (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply):   No fee required.   Fee paid previously with preliminary materials.   Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a -6 (i)(1) and 0 -11 .   Table of Contents September 10, 2024 Dear Fellow Bluejay Diagnostics, Inc. Stockholders: We invite you to attend a Special Meeting of Stockholders of Bluejay Diagnostics, Inc. on October 23, 2024 (t he “Speci al Meeting”). The Special Meeting will begin at 1:00 p.m. local time at the corporate offices of Blueja y Dia gnostics, Inc., 360 Massachusetts Avenue, Suite 203, Acton, MA 01720. Information regarding each of the matters to be voted on at the Special Meeting is contained in the attached Proxy Statement and Notice of Special Meeting of Stockholders. The Notice of Special Meeting of Stockholders sets forth the proposals that will be presented at the Special Meeting, which are described in more detail in the Proxy Statement. Your vote is very important to us. Even if you plan to attend the Special Meeting, we encourage all of our stockholders to review these proxy materials and vote your shares prior to the Special Meeting. On behalf of the Board of Directors, thank you for your continued confidence and investment in Bluejay Diagnostics, Inc.   Very truly yours,     BLUEJAY DIAGNOSTICS, INC.     / s / Neil Dey     Neil Dey     President and Chief Executive Officer Important Notice Regarding the Availability of Proxy Materials for the Special Meeting of Shareholders to be Held on October 23, 2024: An Electronic Copy of the Proxy Statement is available at https: // www.cstproxy.com / bluejaydx / sms2024   Table of Contents Bluejay Diagnostics, Inc. 360 Massachusetts Avenue, Suite 203 Acton, MA 01720 (844) 327-7078 NOTICE OF SPECIAL MEETING OF STOCKHOLDERS TO BE HELD ON OCTOBER 23 , 2024 TO THE STOCKHOLDERS OF BLUEJAY DIAGNOSTICS, INC.: NOTICE IS HEREBY GIVEN that a Special Meeting of Stockholders of Bluejay Diagnostics, Inc. (the “Company”) will be held at the corporate offices at 360 Massachusetts Avenue, Suite 203, Acton, MA 01720, on October 23, 2024 at 1:00 p.m., local time (the “Special Meeting”), for the following purposes, as described in the accompanying Proxy Statement:      Proposal 1.   To approve and adopt an amendment to the Company’s amended and restated certificate of incorporation, as amended, to effect a reverse stock split of the Company’s common stock (the “Reverse Stock Split Proposal”);      Proposal 2.   To approve one or more adjournments of the Special Meeting, if necessary or appropriate, to solicit additional proxies in favor of the Reverse Stock Split Proposal (the “Adjournment Proposal”) if there are not sufficient votes at the Special Meeting to approve and adopt the Reverse Stock Split Proposal. These matters are more fully described in the Proxy Statement for the Special Meeting. Only stockholders of record at the close of business on September 9, 2024 will be entitled to notice of and to vote at the Special Meeting or any adjournment or postponement thereof. All stockholders are cordially invited to attend the Special Meeting. We are providing proxy material access to our stockholders via the Internet at https: // www.cstproxy.com / bluejaydx / sms2024 . Please give the proxy materials your careful attention. In addition to its availability at https: // www.cstproxy.com / bluejaydx / sms2024 , the Proxy Statement is available for viewing, printing and downloading at https: // ir.bluejaydx.com / . YOUR VOTE IS VERY IMPORTANT. WHETHER OR NOT YOU PLAN TO ATTEND THE MEETING, PLEASE SIGN AND D